Metastatic Determinants: Breast Tumour Cells in Circulation

作者: Nisha Kanwar , Susan J. Done

DOI: 10.1007/978-1-62703-634-4_10

关键词:

摘要: More than 90 % of deaths from breast cancer are a result metastases, rather the primary tumour. In recent years it has become possible to study occult steps metastasis that have previously been clinically undetectable—single tumour cells disseminated early on and en route distant sites. High-resolution genomic gene analyses these rare show they carry their own unique sets aberrations frequently quite different tumours originated from. They appear be heterogeneous in transitional state, expressing genes necessary allow them passage into circulation as well required see through survival or dormancy blood vessels metastatic niches such bone marrow lymph nodes. possess signatures ranging up-regulation associated with invasiveness expression favourable growth factor receptors facilitate extravasation at secondary Circulating (CTCs) (DTCs) reported strong prognostic relevance by predicting relapse both late stages cancer. emerging promising biomarkers for monitoring response treatment, whereby drop cell numbers is suggestive positive response, but persisting indicate resistance poor prognosis. It apparent not just need targeted, also intermediate transition do necessarily reflect genetics may eventually give rise to. As more markers being consecutively added growing panel, nature becoming evident, paving way systemic approach experimental design treatment regimens. Molecular characterization single bloodstream will help address many questions surrounding development metastasis.

参考文章(63)
Antonio Giordano, Massimo Cristofanilli, CTCs in metastatic breast cancer Recent results in cancer research. ,vol. 195, pp. 193- 201 ,(2012) , 10.1007/978-3-642-28160-0_18
Ruud Brakenhoff, Klaus Pantel, Guido Sauter, Jacqueline Cloos, Paul van Diest, Fritz Jänicke, Ute Woelfle, Lutz Riethdorf, Molecular signature associated with bone marrow micrometastasis in human breast cancer Cancer Research. ,vol. 63, pp. 5679- 5684 ,(2003)
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale, Insight into the heterogeneity of breast cancer through next-generation sequencing Journal of Clinical Investigation. ,vol. 121, pp. 3810- 3818 ,(2011) , 10.1172/JCI57088
F Farace, C Massard, N Vimond, F Drusch, N Jacques, F Billiot, A Laplanche, A Chauchereau, L Lacroix, D Planchard, S Le Moulec, F André, K Fizazi, J C Soria, P Vielh, A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. British Journal of Cancer. ,vol. 105, pp. 847- 853 ,(2011) , 10.1038/BJC.2011.294
Shang-mian Yie, Be Lou, Shang-rong Ye, Mei Cao, Xu He, Ping Li, Kang Hu, Lin Rao, Sheng-min Wu, Hai-bo Xiao, En Gao, Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse Annals of Surgical Oncology. ,vol. 15, pp. 3073- 3082 ,(2008) , 10.1245/S10434-008-0069-X
HARRIET WIKMAN, ROBERT VESSELLA, KLAUS PANTEL, Cancer micrometastasis and tumour dormancy. Apmis. ,vol. 116, pp. 754- 770 ,(2008) , 10.1111/J.1600-0463.2008.01033.X
Julian A. Schardt, Manfred Meyer, Claudia H. Hartmann, Falk Schubert, Oleg Schmidt-Kittler, Christine Fuhrmann, Bernhard Polzer, Marco Petronio, Roland Eils, Christoph A. Klein, Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell. ,vol. 8, pp. 227- 239 ,(2005) , 10.1016/J.CCR.2005.08.003
Jaco Kraan, Stefan Sleijfer, Michiel H. Strijbos, Michail Ignatiadis, Dieter Peeters, Jean-Yves Pierga, Francoise Farace, Sabine Riethdorf, Tanja Fehm, Laura Zorzino, Arjan G. J. Tibbe, Marisa Maestro, Rafael Gisbert-Criado, Graeme Denton, Johann S. de Bono, Caroline Dive, John A. Foekens, Jan W. Gratama, External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study. Cytometry Part B-clinical Cytometry. ,vol. 80, pp. 112- 118 ,(2011) , 10.1002/CYTO.B.20573
T. R. Cawthorn, E. Amir, R. Broom, O. Freedman, D. Gianfelice, D. Barth, D. Wang, I. Holen, S. J. Done, M. Clemons, Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples. Clinical & Experimental Metastasis. ,vol. 26, pp. 935- 943 ,(2009) , 10.1007/S10585-009-9284-5